1987
DOI: 10.1038/327524a0
|View full text |Cite
|
Sign up to set email alerts
|

Nitric oxide release accounts for the biological activity of endothelium-derived relaxing factor

Abstract: Endothelium-derived relaxing factor (EDRF) is a labile humoral agent which mediates the action of some vasodilators. Nitrovasodilators, which may act by releasing nitric oxide (NO), mimic the effect of EDRF and it has recently been suggested by Furchgott that EDRF may be NO. We have examined this suggestion by studying the release of EDRF and NO from endothelial cells in culture. No was determined as the chemiluminescent product of its reaction with ozone. The biological activity of EDRF and of NO was measured… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1

Citation Types

59
4,336
2
146

Year Published

1989
1989
2016
2016

Publication Types

Select...
10

Relationship

0
10

Authors

Journals

citations
Cited by 9,990 publications
(4,602 citation statements)
references
References 0 publications
59
4,336
2
146
Order By: Relevance
“…These in vivo observations would suggest that the mechanism reported here, namely lipoxin-induced prostacyclin generation by endothelium, can play a role in the intact circulatory system. In addition, lipoxins may also be involved in the release of other endothelialderived relaxing factors [20,21] such as nitric oxide [22]. On the other hand, the vasoconstriction of the splanchnic circulation observed upon systemic injection of lipoxin A4 and lipoxin B4 [7] may be mediated through their ability to generate other vasoactive agents such as thromboxane [16,17].…”
Section: Discussionmentioning
confidence: 99%
“…These in vivo observations would suggest that the mechanism reported here, namely lipoxin-induced prostacyclin generation by endothelium, can play a role in the intact circulatory system. In addition, lipoxins may also be involved in the release of other endothelialderived relaxing factors [20,21] such as nitric oxide [22]. On the other hand, the vasoconstriction of the splanchnic circulation observed upon systemic injection of lipoxin A4 and lipoxin B4 [7] may be mediated through their ability to generate other vasoactive agents such as thromboxane [16,17].…”
Section: Discussionmentioning
confidence: 99%
“…This fact further amplifies the physiological and pathological significance of XOR. Unlike NO synthase, XOR can produce • NO under anoxic conditions and, thus, promote the • NO-dependent vasodilatation in ischaemic tissues [20]. On the other hand, ONOO -, a powerful oxidant and destructive agent, which results from the diffusioncontrolled reaction between • NO and O 2…”
Section: Introductionmentioning
confidence: 99%
“…What is the mechanism of ACh-mediated vasodilation? The vascular endothelium of large blood vessels synthesizes the vasodilator NO during exposure to acetylcholine [41,42]. Consistently, cholinergic vasodilation of murine retinal arterioles was also shown to be primarily mediated by NO, since blockade of NO production almost completely abolished responses to ACh.…”
Section: Neuronal Control Of Blood Flow: a Role For Cholinergic Regulmentioning
confidence: 79%